Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples

When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples

Thumbnail Image
Download
Name

jcm-12-03625-v3.pdf

Size

482 KB

Format

Adobe PDF

Checksum (MD5)

21e0d87bae52f9109df8a4c479ead428

Download all files submitted through automated deposit
packager-6483228a.zip (408.01 KB)
Author(s)
Scheim, David E.
•
Aldous, Colleen
•
Osimani, Barbara
•
Fordham, Edmund J.
•
Hoy, Wendy E.
Date Issued
May 23, 2023
Publisher
Multidisciplinary Digital Publishing Institute
Citation
Journal of Clinical Medicine 12 (11): 3625 (2023)
Version
Final published version
Abstract
Under exceptional circumstances, including high rates of protocol non-compliance, per-protocol (PP) analysis can better indicate the real-world benefits of a medical intervention than intention-to-treat (ITT) analysis. Exemplifying this, the first randomized clinical trial (RCT) considered found that colonoscopy screenings were marginally beneficial, based upon ITT analysis, with only 42% of the intervention group actually undergoing the procedure. However, the study authors themselves concluded that the medical efficacy of that screening was a 50% reduction in colorectal cancer deaths among that 42% PP group. The second RCT found a ten-fold reduction in mortality for a COVID-19 treatment drug vs. placebo by PP analysis, but only a minor benefit by ITT analysis. The third RCT, conducted as an arm of the same platform trial as the second RCT, tested another COVID-19 treatment drug and reported no significant benefit by ITT analysis. Inconsistencies and irregularities in the reporting of protocol compliance for this study required consideration of PP outcomes for deaths and hospitalizations, yet the study coauthors refused to disclose them, instead directing inquiring scientists to a data repository which never held the study’s data. These three RCTs illustrate conditions under which PP outcomes may differ significantly from ITT outcomes and the need for data transparency when these reported or indicated discrepancies arise.
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
https://hdl.handle.net/1721.1/150888
DOI of Published Version
https://doi.org/10.3390/jcm12113625
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.